StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Northwest Biotherapeutics's enterprise value was $270.60M on Oct 19, 2026, against $365.90M a year earlier. Over the last 5 years it ranged from -$3.48M to $1.03B, with a median of $444.30M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$270.60M-22.7%
2025Dec 31, 2025$349.94M-5.7%
2024Dec 31, 2024$371.17M-54.0%
2023Dec 29, 2023$806.51M–
2022Dec 30, 2022-$3.48M-100.6%
2021Dec 31, 2021$632.84M-46.9%
2020Dec 31, 2020$1.19B+838.4%
2019Dec 31, 2019$127.07M+14.0%
2018Dec 31, 2018$111.46M+52.1%
2017Dec 29, 2017$73.27M+79.7%
2016Dec 30, 2016$40.78M-83.3%
2015Dec 31, 2015$244.80M-26.1%
2014Dec 31, 2014$331.47M+145.0%
2013Dec 31, 2013$135.27M–
2012Dec 31, 2012-$397.76K–
2011Dec 30, 2011-$1.61M–

More Northwest Biotherapeutics figures

See a number that looks wrong?